Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results. (Q50688251)
Jump to navigation
Jump to search
scientific article published in February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results. |
scientific article published in February 2007 |
Statements
Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results (English)
Francesca Botta
Erika Di Betta
Gianluca Aliberti
Sergio Bavusi
Alessandro Massimo Gianni
Emilio Bombardieri
1 February 2007